APA aipamena

Liu, H., Lam, H. C., Baglini, C. V., Nijmeh, J., Cottrill, A. A., Chan, S. Y., & Henske, E. P. (2019). Rapamycin-upregulated miR-29b promotes mTORC1-hyperactive cell growth in TSC2-deficient cells by downregulating tumor suppressor retinoic acid receptor β (RARβ). Oncogene.

Chicago Style aipamena

Liu, Heng-Jia, Hilaire C. Lam, Christian V. Baglini, Julie Nijmeh, Alischer A. Cottrill, Stephen Y. Chan, and Elizabeth P. Henske. "Rapamycin-upregulated MiR-29b Promotes MTORC1-hyperactive Cell Growth in TSC2-deficient Cells By Downregulating Tumor Suppressor Retinoic Acid Receptor β (RARβ)." Oncogene 2019.

MLA aipamena

Liu, Heng-Jia, et al. "Rapamycin-upregulated MiR-29b Promotes MTORC1-hyperactive Cell Growth in TSC2-deficient Cells By Downregulating Tumor Suppressor Retinoic Acid Receptor β (RARβ)." Oncogene 2019.